Top 300 BBW Flashcards
Alprazolam BBW
Concurrent use with opioids
Amiodarone BBW
Arrhythmias, hepatotoxicity, proarrhythmic effects, pulmonary toxicity
Amitriptyline BBW
Suicidality; not approved for children <12 y of age
Apixaban BBW
Premature discontinuation increases risk of thrombotic events; increased risk of spinal hematoma with spinal puncture or neuraxial anesthesia
Aripiprazole BBW
Dementia, suicidality
Atenolol BBW
Avoid abrupt withdrawal
Atomoxetine BBW
Suicidality in children and adolescents
Azathioprine BBW
Malignancy
Baclofen BBW
Avoid abrupt discontinuation of oral or intrathecal product
Benazepril BBW
Pregnancy, fetal toxicity
Budesonide/Formoterol BBW
Asthma deaths; pediatrics, increased risk of hospitalization
Bupropion BBW
Suicidality; neuropsychiatric reactions
Canagliflozin BBW
Lower limb amputation
Candesartan BBW
Pregnancy
Carbamazepine BBW
Agranulocytosis, aplastic anemia; dermatological reactions (especially in asians); screen for HLA-B*15:02
Celecoxib BBW
GI toxicity, cardiotoxicity, CABG
Ciprofloxacin BBW
May exacerbate muscle weakness in patients with myasthenia gravis, tendon inflammation and rupture, peripheral neuropathy, CNS effects, cardiac, dermatologic, and hypersensitivity reactions, aortic dissection and rupture, hypoglycemia, mental health adverse effects
Citalopram BBW
Suicidal ideation; not approved for use in children
Clindamycin BBW
Colitis
Clobazam BBW
Concurrent use with opioids, abuse and addition, dependence and withdrawal reactions
Clonazepam BBW
Concurrent use with opioids, abuse, misuse, addiction, dependence, and withdrawal reactions
Clonidine BBW
Epidural use
Clopidogrel BBW
Reduced CYP2C19 function
Codeine BBW
Hepatotoxicity; Children who are CYP2D6 ultrarapid metabolizers; serious risks of misuse, abuse, addiction, overdose, and death; concurrent use with benzodiazepines; immediate release only; serious risk of misuse, accidental ingestion, neonatal opioid withdrawal syndrome
Conjugated Estrogens BBW
Breast cancer, cardiovascular disease, endometrial cancer, dementia risks
Dabigatran BBW
Use in elderly; risk of stroke at discontinuation; spinal epidural hematoma
Darbepoetin BBW
Increased CV, stroke, mortality risk; cancer recurrence
Desvenlafaxine BBW
Suicidality; not for use in children; not for bipolar disorder
Dexmethylphenidate BBW
Tolerance and dependence
Diazepam BBW
Concurrent use with opioids
Diclofenac BBW
Cardiovascular, GI risk, CABG
Divalproex BBW
Hepatotoxicity, teratogenicity, pancreatitis
Doxepin BBW
Suicidality
Dulaglutide BBW
Risk of thyroid cancers
Duloxetine BBW
Suicidality; not approved for children
Edoxaban BBW
Premature discontinuation increases risk of thrombotic events; increased risk of spinal hematoma with spinal puncture or neuraxial anesthesia; reduced efficacy in nonvalvular atrial fibrillation patients with CrCl >95 mL/min
Febuxostat BBW
Increased risk of death (cardiac, all-cause)
Fentanyl BBW
CYP3A4/5 inhibitors; respiratory depression; transdermal not for use postoperatively; fatalities in children; formulations not interchangeable; fever; care with disposal; REMS program; concurrent use with benzodiazepines or other CNS depressants
Fluoxetine BBW
Suicidality; approved in children >7 years of age
Fluticasone/Salmeterol BBW
Increased asthma-related deaths
Fosinopril BBW
Pregnancy
Furosemide BBW
Fluid and electrolyte loss
Hydrocodone BBW
Addiction, abuse, misuse, REMS, respiratory depression, accidental ingestion, neonatal opioid withdrawal, alcohol, CYP3A4/5 interactions, hepatotoxicity, concurrent use with benzodiazepines
Ibuprofen BBW
Cardiovascular events, GI toxicity, CABG
Indomethacin BBW
Cardiovascular events, GI toxicity, CABG